Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Endocrine 2Head & Neck 1

Conditions

Glioma 4Hypoglycemia 2Glioblastoma 2Parkinsonian Disorders 1Parathyroid Neoplasms 1Neoplasms 1Multiple Endocrine Neoplasia 1Insulinoma 1Infant, Newborn, Diseases 1Hyperparathyroidism 1Hyperinsulinism 1Hypercalcemia 1Glucose Metabolism Disorders 1Brain Neoplasms 1

Interventions

fluorodopa F 18 2gallium Ga 68 dotatate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Hypoglycemia × fluorodopa F 18 × Clear all
NCT05088798 2025-12-19

18FDOPA HI

Washington University School of Medicine

Phase 2 Recruiting
100 enrolled
Endocrine

Hyperinsulinism, Hypoglycemia, Infant, Newborn, Diseases, Insulinoma, Glucose Metabolism Disorders

NCT00001277 2022-06-07

Studies of Elevated Parathyroid Activity

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
1,553 enrolled 8 charts
EndocrineHead & Neck

Hypercalcemia, Hyperparathyroidism, Hypoglycemia, Multiple Endocrine Neoplasia, Parathyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡